魏京霞, 李丽淑. 阿托伐他汀钙治疗糖尿病合并动脉粥样硬化性疾病的疗效观察[J]. 实用临床医药杂志, 2020, 24(2): 101-103. DOI: 10.7619/jcmp.202002029
引用本文: 魏京霞, 李丽淑. 阿托伐他汀钙治疗糖尿病合并动脉粥样硬化性疾病的疗效观察[J]. 实用临床医药杂志, 2020, 24(2): 101-103. DOI: 10.7619/jcmp.202002029
WEI Jingxia, LI Lishu. Effect observation of atorvastatin calcium in the treatment of diabetes mellitus complicated with atherosclerotic diseases[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 101-103. DOI: 10.7619/jcmp.202002029
Citation: WEI Jingxia, LI Lishu. Effect observation of atorvastatin calcium in the treatment of diabetes mellitus complicated with atherosclerotic diseases[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 101-103. DOI: 10.7619/jcmp.202002029

阿托伐他汀钙治疗糖尿病合并动脉粥样硬化性疾病的疗效观察

Effect observation of atorvastatin calcium in the treatment of diabetes mellitus complicated with atherosclerotic diseases

  • 摘要: 目的 探讨阿托伐他汀治疗糖尿病合并动脉粥样硬化性疾病的临床疗效 方法 选取2017年1月—2018年6月作者所在两家医院内分泌科收治的221例糖尿病合并动脉粥样硬化性疾病患者,随机分为2组。采用常规药物治疗的113例患者作为对照组,在常规药物治疗的基础上加用阿托伐他汀钙治疗的108例患者作为观察组。比较2组临床疗效。 结果 观察组患者总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)及空腹血糖(FPG)水平显著低于对照组(P<0.05); 2组患者高密度脂蛋白胆固醇(HDL-C)差异无统计学意义(P>0.05)。观察组总有效率显著高于对照组(P<0.05)。观察组患者颈总动脉内中膜厚度显著小于对照组(P<0.05); 观察组患者颈动脉斑块发生率显著低于对照组(P<0.05)。 结论 在常规药物治疗的基础上加用阿托伐他汀钙治疗糖尿病合并动脉粥样硬化性疾病患者的疗效显著。

     

    Abstract: Objective To explore the clinical efficacy of atorvastatin calcium in the treatment of diabetes mellitus complicated with atherosclerotic diseases. Methods From January 2017 to June 2018, a total of 221 diabetic patients with atherosclerotic diseases in hospitals the two authors worked were randomly divided into two groups. Among them, 113 patients treated by conventional medicine were selected as the control group, and 108 patients treated by atorvastatin calcium on the basis of conventional medicine were selected as observation group. The clinical effect was compared between the two groups. Results The levels of total cholesterol(TC), triglyceride(TG), low-density lipoprotein cholesterol(LDL-C)and fasting blood glucose(FPG)in the observation group were significantly lower than those in the control group(P<0.05). There was no significant difference in HDL-C between the two groups(P>0.05). The total effective rate of the observation group was significantly higher than that of the control group(P<0.05). The intima-media thickness of common carotid artery in the observation group was significantly thinner than that in the control group(P<0.05). The incidence rate of carotid plaque in the observation group was significantly lower than that in the control group(P<0.05). Conclusion Additional use of atorvastatin calcium on the basis of routine drug treatment is effective in treating diabetic patients with atherosclerotic diseases.

     

/

返回文章
返回